American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1640)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (686)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (588)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1640)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2703)
  2. Clinical Cancer Research (1446)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • missense-kinase-toolkit: A toolkit to facilitate kinase sequence and structure-based modeling for property predictions
    Meeting Abstract

    White, J.; Tansey, W.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • An active learning platform for predictive oncology in rare cancers
    Meeting Abstract

    Tosh, C.; Sanchez, G. I.; Stockfisch, E.; Kung, A.; Dela Cruz, F.; Slotkin, E.; Tansey, W.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Improving global access to genomic profiling in rare pediatric cancers
    Journal Article

    Sait, S. F.; O’Donohue, T. J.; Bale, T.; Bowman, A.; Hill, K.; Stockfisch, E.; Giantini-Larsen, A.; Alano, T.; Rosenblum, M.; Benhamida, J.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Clinicopathologic features, molecular landscape, and prognostic implications of ovarian low-grade serous tumors with histologic transformation
    Journal Article

    Chui, M. H.; Kang, E. Y.; Kahn, R. M.; Chiang, S.; Zhou, Q.; Iasonos, A.; Manning-Geist, B.; Selenica, P.; Da Cruz Paula, A.; Long Roche, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • ctDNA analysis in ERBB2-amplified colorectal cancer: Biomarker analysis of the MyPathway trial
    Journal Article

    Meric-Bernstam, F.; Raghav, K. P. S.; Sweeney, C. J.; Swanton, C.; Spigel, D. R.; Bose, R.; Burris, H. A.; Friedman, C. F.; Espenschied, C. R.; Grindheim, J. M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Cancer research in the age of big data
    Editorial

    Iacobuzio-Donahue, C. A.
    Cancer Research (2025)

    Fulltext@MSK | Save
  • SCD1 inhibition blocks the AKT–NRF2–SLC7A11 pathway to induce lipid metabolism remodeling and ferroptosis priming in lung adenocarcinoma
    Journal Article

    Sen, U.; Coleman, C.; Gandhi, N.; Jethalia, V.; Demircioglu, D.; Elliott, A.; Vanderwalde, A. M.; Hayatt, O.; de Stanchina, E.; Halmos, B.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Factors associated with disease progression after discontinuation of immune checkpoint inhibitors for immune-related toxicity in patients with advanced non-small cell lung cancer
    Journal Article

    Pecci, F.; Thummalapalli, R.; Alden, S. L.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Jeng, M.; Egger, J. V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase I study of FHD-286, a dual BRG1/BRM (SMARCA4/SMARCA2) inhibitor, in patients with advanced myeloid malignancies
    Journal Article

    DiNardo, C. D.; Fathi, A. T.; Kishtagari, A.; Bhalla, K. N.; Quintás-Cardama, A.; Reilly, S. A.; Almon, C.; Patriquin, C.; Nabhan, S.; Healy, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Modeling MRD changes in myeloma to understand treatment effects, predict outcomes, and investigate curative potential
    Journal Article

    Gregory, W. M.; Prior, T. J.; Blake Bartlett, J.; Sonneveld, P.; Dimopoulos, M. A.; Moreau, P.; Usmani, S.; Facon, T.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: